United States
About Endo Inc.
Endo Inc. is a specialty pharmaceutical company that develops, manufactures, markets, and sells a diverse range of pharmaceutical products in the United States and internationally. Founded in 1997 and headquartered in Malvern, Pennsylvania, the company focuses on treatments for urology, orthopedics, and endocrinology.
Key Products and Treatments
- XIAFLEX: Currently in clinical development for conditions such as plantar fibromatosis and plantar fasciitis, with additional pre-clinical studies for arthrofibrosis of the knee.
- ADRENALIN: A non-selective alpha and beta adrenergic agonist used for emergency treatment of severe allergic reactions, including anaphylaxis.
- VASOSTRICT: Designed to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite other treatments.
- APLISOL: A sterile solution for diagnosing tuberculosis through intradermal administration.
- SUPPRELIN LA: A 12-month hydrogel implant delivering histrelin acetate for treating central precocious puberty (CPP) in children.
- AVEED & TESTOPEL: Long-acting testosterone treatments for hypogonadism and testosterone replacement therapy (TRT).
- EDEX: A penile injection therapy for erectile dysfunction caused by nerve, vascular, or emotional factors.
Product Formats
Endo Inc. provides a variety of pharmaceutical formats, including:
- Solid oral extended-release and immediate-release products
- Liquids, semi-solids, and powders
- Patches, ophthalmics, and sprays
